Repurposing Siddha mercurial drug for mild to moderate COVID-19 - Case series and exploration of its chemical profile.

Shiva S, Mari S, Amuthan A, Shanmugam R

Open source

DOI
10.1016/j.jaim.2021.06.009
Published
2022 Apr-Jun
Container
Journal of Ayurveda and integrative medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jaim.2021.06.009,
  title = {Repurposing Siddha mercurial drug for mild to moderate COVID-19 - Case series and exploration of its chemical profile.},
  author = {Shiva S and Mari S and Amuthan A and Shanmugam R},
  year = {2022},
  journal = {Journal of Ayurveda and integrative medicine},
  doi = {10.1016/j.jaim.2021.06.009},
  url = {https://doi.org/10.1016/j.jaim.2021.06.009}
}

RIS

TY  - JOUR
TI  - Repurposing Siddha mercurial drug for mild to moderate COVID-19 - Case series and exploration of its chemical profile.
AU  - Shiva S
AU  - Mari S
AU  - Amuthan A
AU  - Shanmugam R
PY  - 2022
JO  - Journal of Ayurveda and integrative medicine
DO  - 10.1016/j.jaim.2021.06.009
UR  - https://doi.org/10.1016/j.jaim.2021.06.009
ER  - 

APA

S, S., S, M., A, A., & R, S. (2022). Repurposing Siddha mercurial drug for mild to moderate COVID-19 - Case series and exploration of its chemical profile.. Journal of Ayurveda and integrative medicine. https://doi.org/10.1016/j.jaim.2021.06.009

Source records